Paulson & Co’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$729M Sell
1,392,188
-315,334
-18% -$151M 23.42% 2
2025
Q4
$994M Sell
1,707,522
-200,001
-10% -$102M 30.48% 1
2025
Q3
$875M Sell
1,907,523
-182,000
-9% -$67.9M 29.46% 1
2025
Q2
$632M Sell
2,089,523
-10,000
-0.5% -$2.98M 31.44% 1
2025
Q1
$695M Buy
2,099,523
+57,523
+3% +$18.9M 39.81% 1
2024
Q4
$630M Hold
2,042,000
38.14% 1
2024
Q3
$393M Buy
2,042,000
+192,000
+10% +$49.1M 27.55% 1
2024
Q2
$518M Buy
1,850,000
+75,000
+4% +$17.9M 38.31% 1
2024
Q1
$474M Buy
1,775,000
+669,259
+61% +$158M 32.74% 1
2023
Q4
$256M Buy
1,105,741
+605,741
+121% +$106M 23.09% 1
2023
Q3
$73M Buy
500,000
+149,800
+43% +$28.2M 6.53% 6
2023
Q2
$80.9M Buy
+350,200
New +$94.9M 7.9% 5

Other funds holding MDGL